Understanding how AB-PINACA interacts with cannabinoid receptors can provide insights into opportunity therapeutic programs as well as mechanisms of cannabinoid-connected Diseases.AB-PINACA is assessed as a synthetic cannabinoid receptor agonist, that means it binds to CB1 and CB2 receptors to mimic the consequences of organic cannabinoids. These